SMAD7 and liver cancer: Shikonin inhibited cell progression and EMT and accelerated cell death by regulating the miR-106b/Recombinant Mothers Against Decapentaplegic Homolog 7 (SMAD7)/TGF-β signaling pathway to achieve the desired therapeutic effect in liver cancer treatment [43].